Form 4: 908 Devices CFO Joseph Griffith IV Acquires Stock Options and Restricted Stock Units
SEC Form 4 Filing
Joseph H. Griffith IV, CFO of 908 Devices Inc., reports acquisition of stock options and restricted stock units.
Summary
- On March 1, 2024, Joseph H. Griffith IV, the Chief Financial Officer of 908 Devices Inc., acquired stock options for 61,535 shares with an exercise price of $7.35.
- These options vest over time, starting with 25% on February 1, 2025, and the remainder in monthly installments over the following 36 months.
- Griffith also acquired 45,042 Restricted Stock Units (RSUs) on the same date.
- These RSUs vest with 25% on February 1, 2025, and the remaining 75% vesting in three equal annual installments thereafter.
- The reporting person's continued service is required for the vesting of both the options and RSUs.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, aligning management interests with shareholders. There are no immediate negative implications.
Positives
- The acquisition of stock options and RSUs by the CFO aligns his interests with those of the shareholders, incentivizing him to work towards the company's success.
- The vesting schedules encourage long-term commitment from the CFO.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for incentivizing and retaining key personnel.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of executive compensation in the technology and life sciences industries, often used to align management's interests with shareholder value.
- Vesting schedules similar to the ones described (25% after one year, then monthly or annual vesting) are standard practice to ensure long-term commitment.
- Companies like Thermo Fisher Scientific, Agilent Technologies, and Danaher Corporation also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- Shareholders may view this as a positive sign, as it aligns the CFO's interests with the company's long-term success.
- Employees may see this as a sign of stability and commitment from the management team.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: Acquisition of stock options and restricted stock units. |
| 02/01/2025 | First vesting date for 25% of both stock options and restricted stock units. |
| 02/28/2034 | Expiration date of the stock options. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.